INSIGHTS ON PHARMACEUTICAL PACKAGING

• Characterizing The E&L Profile Of Stoppers For Drug Stability

  The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.

• Vial Containment Systems Based On Elastomer 4031/45 Gray

  Examine the results of two, two-year studies that indicate good container closure integrity performance that can be achieved with stoppers of a given elastomer, independent of configuration.

• The Importance Of Containment In Oral Solid Dose Packaging Systems

  Containment is growing in importance due to increasingly stringent legal requirements for packaging solid medicines. Learn in detail about containment solutions for the pharmaceutical industry.

• Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization

  While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.

• How To Optimize Labeling In A Pharmaceutical Environment

  5/29/2025

  Accurate, readable pharmaceutical labels are crucial. Learn to navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.

• Autoinjectors For Autoimmune Diseases: Benefits And Considerations

  8/7/2025

  By improving convenience, ensuring precise dosing, and reducing dependency on healthcare facilities, autoinjectors enhance patient outcomes and quality of life.

• FAQs On The Revised EU GMP Annex 1: Volume 1

  3/5/2025

  The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.

• Providing Packing And Blinding Solutions For An Innovative Drug Start-Up

  9/13/2024

  Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.

• A Robust Extractables Data Package Helps Drive Patient Safety

  10/1/2024

  Complex drug product formulations are more common, so it is imperative to have a deeper knowledge of extractables to understand risks associated with potential interactions between packaging and product.